Literature DB >> 10549291

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.

N Kubota1, Y Terauchi, H Miki, H Tamemoto, T Yamauchi, K Komeda, S Satoh, R Nakano, C Ishii, T Sugiyama, K Eto, Y Tsubamoto, A Okuno, K Murakami, H Sekihara, G Hasegawa, M Naito, Y Toyoshima, S Tanaka, K Shiota, T Kitamura, T Fujita, O Ezaki, S Aizawa, T Kadowaki.   

Abstract

Agonist-induced activation of peroxisome proliferator-activated receptor gamma (PPAR gamma) is known to cause adipocyte differentiation and insulin sensitivity. The biological role of PPAR gamma was investigated by gene targeting. Homozygous PPAR gamma-deficient embryos died at 10.5-11.5 dpc due to placental dysfunction. Quite unexpectedly, heterozygous PPAR gamma-deficient mice were protected from the development of insulin resistance due to adipocyte hypertrophy under a high-fat diet. These phenotypes were abrogated by PPAR gamma agonist treatment. Heterozygous PPAR gamma-deficient mice showed overexpression and hypersecretion of leptin despite the smaller size of adipocytes and decreased fat mass, which may explain these phenotypes at least in part. This study reveals a hitherto unpredicted role for PPAR gamma in high-fat diet-induced obesity due to adipocyte hypertrophy and insulin resistance, which requires both alleles of PPAR gamma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549291     DOI: 10.1016/s1097-2765(00)80210-5

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  372 in total

Review 1.  Mechanisms of nutritional and hormonal regulation of lipogenesis.

Authors:  S Kersten
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

2.  C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.

Authors:  Evan D Rosen; Chung-Hsin Hsu; Xinzhong Wang; Shuichi Sakai; Mason W Freeman; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

Review 3.  Molecular mechanisms of adipocyte differentiation.

Authors:  Q Tong; G S Hotamisligil
Journal:  Rev Endocr Metab Disord       Date:  2001-10       Impact factor: 6.514

4.  Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice.

Authors:  Tahar Hajri; Xiao Xia Han; Arend Bonen; Nada A Abumrad
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

5.  Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache.

Authors:  E D Rosen; B M Spiegelman
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 6.  Insights into insulin resistance and type 2 diabetes from knockout mouse models.

Authors:  T Kadowaki
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 7.  Control of body weight: a physiologic and transgenic perspective.

Authors:  G Frühbeck; J Gómez-Ambrosi
Journal:  Diabetologia       Date:  2003-02-15       Impact factor: 10.122

8.  A dominant negative PPARgamma mutant shows altered cofactor recruitment and inhibits adipogenesis in 3T3-L1 cells.

Authors:  Y Park; B D Freedman; E J Lee; S Park; J L Jameson
Journal:  Diabetologia       Date:  2003-03-07       Impact factor: 10.122

9.  Differentially expressed genes in PPARγ-deficient MSCs.

Authors:  Yun Su; Xiaona Shen; Jie Chen; Carlos M Isales; Jing Zhao; Xing-Ming Shi
Journal:  Mol Cell Endocrinol       Date:  2017-07-31       Impact factor: 4.102

10.  Oleuropein as an inhibitor of peroxisome proliferator-activated receptor gamma.

Authors:  Michaela Svobodova; Ioanna Andreadou; Alexios-Leandros Skaltsounis; Jan Kopecky; Pavel Flachs
Journal:  Genes Nutr       Date:  2013-12-10       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.